Patients with acquired pure red cell aplasia respond to <scp>PI3Kδ</scp> inhibitor rapidly-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Patients with acquired pure red cell aplasia respond to PI3Kδ inhibitor rapidly

Published:2024-04-12 Issue:7 Volume:99 Page:1431-1433
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Wang Zhenzhen¹^ORCID,Jiang Bo¹,Song Lin¹,Sun Mingyuan¹,Li Chunhong¹,Li Xiaoxia¹,Zheng Weiwei¹,Tao Yuan¹,Sun Qi¹,Qi Junyuan¹

Affiliation:

1. State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Tianjin China

Funder

Chinese Society of Clinical Oncology

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.27325

Reference10 articles.

1. Acquired pure red cell aplasia: updated review of treatment

2. Daratumumab for treatment-refractory acquired idiopathic pure red cell aplasia

3. Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: a Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group

4. Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group

5. The PI3K Pathway in Human Disease

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple drugs;Reactions Weekly;2024-08-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP